Mpex Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Mpex Pharmaceuticals Ownership

Who owns Mpex Pharmaceuticals?

Mpex Pharmaceuticals is owned by Axcan Pharmaceuticals. It was acquired on April 14, 2011.

Was Mpex Pharmaceuticals formerly PE-backed?

Yes. Mpex Pharmaceuticals was formerly owned by 1 private investor.

Mpex Pharmaceuticals Business Overview

Where is Mpex Pharmaceuticals headquartered?

Mpex Pharmaceuticals is headquartered in San Diego, California.

What sector is Mpex Pharmaceuticals in?

Mpex Pharmaceuticals is a life science company.

When was Mpex Pharmaceuticals founded?

Mpex Pharmaceuticals was founded in 2001.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Mpex Pharmaceuticals

Mpex Pharmaceuticals, Inc.

11535 Sorrento Valley Road,
San Diego, California 92121
United States,
(858) 875-2840

Mpex Pharmaceuticals is a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, with a particular focus on gram-negative organisms.

 Subscribe to unlock this and 204,320
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 77K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.